1. Molecular imaging and molecular diagnostics: two sides of the same coin?

   • Marcus Hacker
   • Gregor Hoermann
   • Lukas Kenner

   Editorial 02 June 2018 Pages: 1645 - 1648

2. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions

   • Margarita Kirienko
   • Luca Cozzi
   • Martina Sollini

   Original Article 06 April 2018 Pages: 1649 - 1660

   

3. Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST – multicenter study in Japan

   • Kazuhiro Kitajima
   • Koya Nakatani
   • Yasuo Miyoshi

   Original Article 12 May 2018 Pages: 1661 - 1671

   

4. Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma

   • Pierre Decazes
   • Stéphanie Becker
   • Isabelle Gardin

   Original Article 28 April 2018 Pages: 1672 - 1679

   

5. Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

   • Mariarosaria Incoronato
   • Anna Maria Grimaldi
   • Marco Salvatore

   Original Article 25 April 2018 Pages: 1680 - 1693

   

6. Prognostic value of [¹⁸F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation

   • Antje Stolzenburg
   • Katharina Lückerath
   • Constantin Lapa

   Original Article 02 April 2018 Pages: 1694 - 1704

   

7. Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma

   • Yassine Al Tabaa
   • Emmanuelle Tchernonog
   • Guillaume Cartron

   Short Communication 20 April 2018 Pages: 1705 - 1709

   

8. Diagnostic performance and impact on patient management of ⁶⁸Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours

   • Marie Paquet
   • Mathieu Gauthé
   • Françoise Montravers

   Original Article 12 March 2018 Pages: 1710 - 1720

   

9. Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies

   • Bruno Sangro
   • Carlo Ludovico Maini
   • on behalf of the European Network on Radioembolization with Yttrium-90 resin microspheres (ENRY)

   Original Article Open access 07 March 2018 Pages: 1721 - 1730

   

10. A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and ⁹⁰Y-loaded glass microsphere selective internal radiation therapy

    • Vincent Manceau
    • Xavier Palard
    • Etienne Garin

    Original Article 20 March 2018 Pages: 1731 - 1741

    

11. Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using ¹⁸F-FDG PET/CT

    • Lucas Goense
    • Jelle P. Ruurda
    • Steven H. Lin

    Original Article Open access 16 April 2018 Pages: 1742 - 1751

    

12. Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma

    • Yimin Li
    • Frank Hofheinz
    • Sebastian Zschaeck

    Original Article 21 April 2018 Pages: 1752 - 1761

    

13. ¹⁸F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with ^99mTc-MIBI or ^99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients

    • Mohsen Beheshti
    • Lukas Hehenwarter
    • Christian Pirich

    Original Article Open access 08 March 2018 Pages: 1762 - 1771

    

14. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of ¹⁸F-Fluorocholine PET/CT

    • Serena Grimaldi
    • Jacques Young
    • Désirée Deandreis

    Original Article 22 April 2018 Pages: 1772 - 1780

    

15. Highlights of the 30th Annual Congress of the EANM, Vienna 2017: “Yes we can – make nuclear medicine great again”

    • Stefano Fanti
    • Rachele Bonfiglioli
    • Clemens Decristoforo

    Review Article Open access 03 May 2018 Pages: 1781 - 1794

    

16. Recommendations on nuclear and multimodality imaging in IE and CIED infections

    • Paola Anna Erba
    • Patrizio Lancellotti
    • Gilbert Habib

    Guidelines 24 May 2018 Pages: 1795 - 1815

    

17. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline

    • A. Signore
    • F. Jamar
    • E. Lazzeri

    Guidelines Open access 31 May 2018 Pages: 1816 - 1831

18. Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

    • Eric Laffon
    • Roger Marthan

    Letter to the Editor 17 May 2018 Pages: 1832 - 1833

19. Reply to the letter

    • Hajira Ilyas
    • N. George Mikhaeel
    • Sally F. Barrington

    Reply 31 May 2018 Pages: 1834 - 1835

20. Novel use of ¹⁷⁷Lu-DOTA-RGD₂ in treatment of ⁶⁸Ga-DOTA-RGD₂-avid lesions in papillary thyroid cancer with TENIS

    • Ashwin Singh Parihar
    • Ashwani Sood
    • Bhagwant Rai Mittal

    Image of the Month 01 May 2018 Pages: 1836 - 1837

    

21. Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on ¹⁸F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma

    • Pierre Decazes
    • Stéphanie Becker
    • Isabelle Gardin

    Correction 26 May 2018 Pages: 1838 - 1839